Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Bio-Immunity Recovers Most of Recalled Rabies Vaccine

publication date: Feb 9, 2009

The China operating subsidiary of China Bio-Immunity Corporation has recovered most of the rabies vaccine that was found to have a flaw. Last year, Dalian Jingang-Andi Bio-products Co. (JGAD) of Dalian City Liaoning Province produced 360,200 doses of the vaccine. 321,800 have been recovered as part of a recall operation. The problem with the vaccine seems to be in the nucleic acid materials that were used as an adjuvant to the vaccine, which were called an “illegal ingredient.” More details...

Stock Symbol: (OTCBB: CHHB)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here